Patent Assignment
Reel/Frame 047658/0137
Merger and Change of Name
Recorded: 2018-11-28
Pages: 31
Assignors
DOV PHARMACEUTICAL, INC.
Executed: 2010-07-20
DOV PHARMACEUTICAL, INC.
Executed: 2010-07-20
Assignee
EUTHYMICS BIOSCIENCE, INC.
50 BRAINTREE HILL OFFICE PARK, SUITE 301, BRAINTREE, MASSACHUSETTS, 02184
Covered Property
(1)
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Application:
16/028,257 →
Publication:
US 2019/0070148
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 28, 2018
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 047610/0714 →
Assignment of Assignor's Interest
Nov 28, 2018
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 047658/0784 →
Assignment of Assignor's Interest
Nov 28, 2018
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 047658/0798 →
Merger
Nov 28, 2018
From: NEUROVANCE, INC.
To: OTSUKA AMERICA PHARMACEUTICAL, INC.
Reel/Frame 047659/0642 →